Biotech Series A Investors & VC Firms
1596 firms in this list, with a median first check of $500K. 341 of them lead rounds. Generated from verified public data and updated continuously.
Launch Tennessee
NashvillePre-Seed–Series B
1 person
Emergent Medical Partners, LLP
San JoseSeed–Series A
4 people
TOHOKU University Venture Partners
SendaiPre-Seed–Growth
13 people
Agronomics
LondonSeed–Series B
6 people
Angels Santé
ParisPre-Seed–Series A
12 people
China Growth Capital
BeijingPre-Seed–Series A$1M – $55M
Form Ventures
LondonPre-Seed–Series A$254K – $1.3M
3 people
FundWA
Mount PleasantSeed–Series A
9 people
Shepherd Ventures
San DiegoSeries A–Late Stage$750K – $3M
6 people
Grow Venture Partners
BarcelonaPre-Seed–Series A$108K – $216K
8 people
Takwin Ventures
HaifaSeed–Series A
14 people
Avonmore Developments
LondonPre-Seed–Series A$63K – $315K
4 people
First Spark Ventures, Llc
Menlo ParkPre-Seed–Series A
7 people
Nucleus Capital
BerlinPre-Seed–Series A$1M – $1.1M
7 people
Radix Ventures
WarsawSeed–Late Stage$550K – $2.8M
9 people
Seed Healthcare
DoradoPre-Seed–Series A
12 people
Swell Partners
BrooklynPre-Seed–Series A$500K – $600K
3 people
Vision Incubate
KanazawaPre-Seed–Growth
9 people
Clarevia Ventures
MadisonSeed–Series A$250K – $2.5M
11 people
InHealth Ventures
LondonPre-Seed–Series A$500K – $3M
5 people
Korea Investment Partners
SeoulSeed–Late Stage$973K – $50M
17 people
Moore Venture Partners
San DiegoPre-Seed–Series A
5 people
Prolog Ventures
ClaytonSeries A–Late Stage$250K – $1M
5 people
Salveo Capital
NorthbrookSeed–Late Stage
8 people
Related lists
Series A Investors & VC Firms (7875)Series A Investors & VC Firms in United States (3337)SaaS Series A Investors & VC Firms (2667)AI & Machine Learning Series A Investors & VC Firms (2343)Enterprise Software Series A Investors & VC Firms (2324)Fintech Series A Investors & VC Firms (2239)Healthtech Series A Investors & VC Firms (2210)Series A Investors & VC Firms in Global (2163)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)
Data sourced from public filings and firms' own websites — see our methodology.

























































